Literature DB >> 17786049

COMMD1: a novel protein involved in the proteolysis of proteins.

Bart van de Sluis1, Arjan J Groot, Cisca Wijmenga, Marc Vooijs, Leo W Klomp.   

Abstract

COMMD1 is a protein which is associated with multiple cellular pathways, including NFkappaB signaling, copper homeostasis and sodium transport. Recently we found that COMMD1 is also essential for normal mouse embryogenesis. Embryos deficient for Commd1 are retarded and die between 9.5 and 10.5 dpc. Increased HIF-1 activity and elevated HIF-1alpha protein expression were observed in 9.5 dpc Commd1-deficient embryos. In line with these in vivo data, in vitro studies showed that reduced COMMD1 expression caused increased HIF-1alpha protein stability and HIF-1 activity. Functional characterization of COMMD1 in NFkappaB signaling and ATP7B-dependent biliary copper excretion suggested that COMMD1 also has a role in regulating the protein degradation of RelA (p65) and ATP7B. The exact function of COMMD1 in these pathways remains elusive but these recent studies suggest that COMMD1 is associated with the ubiquitin-proteasomal system for regulating protein stability.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17786049     DOI: 10.4161/cc.6.17.4646

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  9 in total

1.  COMMD1 interacts with the COOH terminus of NKCC1 in Calu-3 airway epithelial cells to modulate NKCC1 ubiquitination.

Authors:  Laura Smith; Paul Litman; Carole M Liedtke
Journal:  Am J Physiol Cell Physiol       Date:  2013-03-20       Impact factor: 4.249

2.  Cu,Zn superoxide dismutase maturation and activity are regulated by COMMD1.

Authors:  Willianne I M Vonk; Cisca Wijmenga; Ruud Berger; Bart van de Sluis; Leo W J Klomp
Journal:  J Biol Chem       Date:  2010-07-01       Impact factor: 5.157

3.  Clusterin and COMMD1 independently regulate degradation of the mammalian copper ATPases ATP7A and ATP7B.

Authors:  Stephanie Materia; Michael A Cater; Leo W J Klomp; Julian F B Mercer; Sharon La Fontaine
Journal:  J Biol Chem       Date:  2011-11-30       Impact factor: 5.157

4.  COMMD1 (copper metabolism MURR1 domain-containing protein 1) regulates Cullin RING ligases by preventing CAND1 (Cullin-associated Nedd8-dissociated protein 1) binding.

Authors:  Xicheng Mao; Nathan Gluck; Baozhi Chen; Petro Starokadomskyy; Haiying Li; Gabriel N Maine; Ezra Burstein
Journal:  J Biol Chem       Date:  2011-07-21       Impact factor: 5.157

5.  COMMD1-mediated ubiquitination regulates CFTR trafficking.

Authors:  Loïc Drévillon; Gaëlle Tanguy; Alexandre Hinzpeter; Nicole Arous; Alix de Becdelièvre; Abdel Aissat; Agathe Tarze; Michel Goossens; Pascale Fanen
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

Review 6.  Canine models of copper toxicosis for understanding mammalian copper metabolism.

Authors:  Hille Fieten; Peter A J Leegwater; Adrian L Watson; Jan Rothuizen
Journal:  Mamm Genome       Date:  2011-12-07       Impact factor: 2.957

7.  The copper-transporting capacity of ATP7A mutants associated with Menkes disease is ameliorated by COMMD1 as a result of improved protein expression.

Authors:  Willianne I M Vonk; Prim de Bie; Catharina G K Wichers; Peter V E van den Berghe; Rozemarijn van der Plaats; Ruud Berger; Cisca Wijmenga; Leo W J Klomp; Bart van de Sluis
Journal:  Cell Mol Life Sci       Date:  2011-06-11       Impact factor: 9.261

8.  COMMD1 Promotes pVHL and O2-Independent Proteolysis of HIF-1alpha via HSP90/70.

Authors:  Bart van de Sluis; Arjan J Groot; Jeroen Vermeulen; Elsken van der Wall; Paul J van Diest; Cisca Wijmenga; Leo W Klomp; Marc Vooijs
Journal:  PLoS One       Date:  2009-10-05       Impact factor: 3.240

Review 9.  Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development.

Authors:  Mayur V Jain; Anna M Paczulla; Thomas Klonisch; Florence N Dimgba; Sahana B Rao; Karin Roberg; Frank Schweizer; Claudia Lengerke; Padideh Davoodpour; Vivek R Palicharla; Subbareddy Maddika; Marek Łos
Journal:  J Cell Mol Med       Date:  2013-01-10       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.